Bourgi, Kassem
Wanjalla, Celestine
Koethe, John R.
Article History
First Online: 30 July 2018
Compliance with Ethical Standards
:
: John R. Koethe receives research funding from Gilead Pharmaceuticals. Kassem Bourgi and Celestine Wanjalla declare that they have no competing interests.
: This article does not contain any studies with human or animal subjects performed by any of the authors.